IRIS UniCatt

Daniele, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.002
NA - Nord America 3.603
AS - Asia 1.973
SA - Sud America 486
AF - Africa 140
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.224
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.525
IT - Italia 1.115
DE - Germania 908
CN - Cina 705
SG - Singapore 704
SE - Svezia 646
BR - Brasile 450
IE - Irlanda 275
FR - Francia 233
UA - Ucraina 176
ID - Indonesia 175
GB - Regno Unito 163
RU - Federazione Russa 115
CI - Costa d'Avorio 113
FI - Finlandia 110
IN - India 90
PL - Polonia 60
TR - Turchia 49
KR - Corea 47
VN - Vietnam 43
CA - Canada 37
AT - Austria 36
NL - Olanda 33
BE - Belgio 32
HK - Hong Kong 32
MX - Messico 30
ES - Italia 29
JP - Giappone 20
TW - Taiwan 18
BD - Bangladesh 17
AU - Australia 16
IR - Iran 12
RO - Romania 11
ZA - Sudafrica 10
CZ - Repubblica Ceca 9
EC - Ecuador 9
PK - Pakistan 9
PT - Portogallo 9
IL - Israele 8
IQ - Iraq 8
CH - Svizzera 7
UZ - Uzbekistan 7
VE - Venezuela 7
AR - Argentina 6
GR - Grecia 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
CO - Colombia 5
MA - Marocco 5
BA - Bosnia-Erzegovina 4
KE - Kenya 4
NO - Norvegia 4
DO - Repubblica Dominicana 3
HR - Croazia 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
NP - Nepal 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
HN - Honduras 2
LK - Sri Lanka 2
LT - Lituania 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
TM - Turkmenistan 2
TN - Tunisia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
BB - Barbados 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GH - Ghana 1
HU - Ungheria 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
UY - Uruguay 1
Totale 10.224
Salva come PNG Salva come JPEG
Città #
Chandler 629
Singapore 442
Ashburn 311
Dublin 255
Jakarta 170
San Mateo 129
Wilmington 125
Milan 119
Jacksonville 114
Abidjan 113
Nanjing 111
Dearborn 106
Rome 106
Boston 93
Princeton 93
Ann Arbor 91
Beijing 82
Moscow 75
Cattolica 66
Woodbridge 65
Redwood City 62
Hefei 61
Fairfield 58
New York 51
Nürnberg 50
Helsinki 46
Seattle 46
The Dalles 43
Warsaw 43
Houston 42
Los Angeles 42
Seoul 41
Nanchang 40
Lawrence 35
Naples 35
Redmond 35
Marseille 34
Nuremberg 33
São Paulo 31
Boardman 30
Frankfurt am Main 28
Bremen 27
Guangzhou 27
Izmir 27
Shenyang 27
Hong Kong 26
Mountain View 26
Norwalk 26
Shanghai 25
London 24
Bari 23
Brussels 23
Changsha 23
Hangzhou 23
Tianjin 21
Kunming 20
Hanoi 19
Munich 19
Chicago 18
Hebei 17
Cambridge 16
Vienna 16
Belo Horizonte 15
Curitiba 15
Detroit 15
Düsseldorf 15
Lancaster 15
Rio de Janeiro 15
Dong Ket 14
Lappeenranta 14
San Jose 14
Fremont 13
Jiaxing 13
Wroclaw 13
Falkenstein 12
Leawood 12
San Diego 12
Leicester 11
Montreal 11
University Park 11
Zhengzhou 11
Bexley 10
Campinas 10
Hyderabad 10
Mascalucia 10
Washington 10
Atlanta 9
Brooklyn 9
Amsterdam 8
Cerveteri 8
Falls Church 8
Las Vegas 8
Portsmouth 8
Pune 8
Rho 8
Saint Louis 8
Berlin 7
Brescia 7
Chennai 7
Lauterbourg 7
Totale 5.065
Salva come PNG Salva come JPEG
Nome #
Neuropsichiatria dei disturbi dell’umore. In: Neuroscienze cliniche e del comportamento. Basi neurobiologiche e neuropsicologiche. Psicopatologia funzionale e neuropsichiatria A cura di C. Blundo 540
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 332
Basi neuro anatomiche delle funzioni cognitive e del comportamento 190
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 152
Sexual Behavior in Women with Bipolar Disorder 146
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 145
Cognitive outcome five years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 144
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 139
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 136
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 131
Extradural motor cortex stimulation improves gait, speech, and language in a patient with pure akinesia 127
Unilateral extradural motor cortex stimulation is safe and improves Parkinson disease at 1 year 121
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 119
Oxidative Stress And Overexpression Of Manganese Superoxide Dismutase In Patients With Alzheimer's Disease. 114
Analysis of blink rate in patients with blepharospasm 109
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 107
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 104
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 100
APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in women 99
New insights into the genetic etiology of Alzheimer's disease and related dementias 99
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 98
Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey 98
Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson’s disease 96
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 95
Neuropsychological features of patients with Parkinson’s disease and impulse control disorders 91
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging. 91
Contribution of Mediterranean Diet in the Prevention of Alzheimer's Disease. 91
Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life 91
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2) 91
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 89
Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease 88
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 87
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 86
An Old Challenge with New Promises: A Systematic Review on Comprehensive Geriatric Assessment in Long-Term Care Facilities 86
Suicidal behaviour in older age: A systematic review of risk factors associated to suicide attempts and completed suicides 86
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 85
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 84
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 83
Cognitive and behavioural changes after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 83
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 80
Freezing of gait in Parkinson's disease: the paradoxical interplay between gait and cognition 80
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 80
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 79
The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset 79
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 78
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 76
Neuroanatomical Correlates of Category-specific Semantic Disorders: A Critical Survey 75
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia 73
Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease 72
FOXP2, APOE, and PRNP: New Modulators in Primary Progressive Aphasia 70
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 70
null 69
Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know? 68
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 67
Social Frailty in the COVID-19 Pandemic Era 66
Early visual memory deficits: a neuropsychological marker of GBA mutations in PD? 63
Oral frailty and its determinants in older age: a systematic review 63
Accelerated Long-Term Forgetting Limited to the Recollection Component of Recognition Memory in a Temporal Lobe Epileptic Patient 62
Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease 62
Early rightwards orienting of attention on simple reaction time performance in patients with left-sided neglect 61
Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease 61
Disproportionate Impairment in Naming and Comprehension of Nouns with Relative Sparing of Verbs in a Patient who Survived Herpes Simplex Encephalitis 60
APOE ε2-ε4 genotype is a possible risk factor for primary progressive aphasia [6] 59
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy 59
Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs 58
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 57
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders 57
The Challenge of Antidepressant Therapeutics in Alzheimer's Disease 57
Zolpidem in Parkinson's disease 56
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 56
Malattia di Parkinson e altri disordini del movimento 56
Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis 55
Polymorphism C in the serotonin 1 transporter gene in depression-free elderly patients with vascular dementia 55
The diagnostic accuracy of late-life depression is influenced by subjective memory complaints and educational level in an older population in Southern Italy 55
Clinical Indicators of Oral Frailty: A Domain-specific Frailty Phenotype 55
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 54
Apolipoprotein E ε4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients 54
Physical Frailty, Multimorbidity, and All-Cause Mortality in an Older Population From Southern Italy: Results from the Salus in Apulia Study 54
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease 53
Phytochemicals in the Treatment of Alzheimer's Disease: A Systematic Review 53
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 53
Can pharmacotherapy effectively reduce Alzheimer’s related agitation? 53
Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease? 53
Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders 52
Cognitive frailty: a potential target for secondary prevention of dementia 52
Processed meat consumption and the risk of incident late-onset depression: a 12-year follow-up of the Salus in Apulia Study 52
The role of biomarkers in psychiatry 50
CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series 50
The relationship between epigenetics and microbiota in neuropsychiatric diseases 50
Estimating the Inheritance of Frontotemporal Lobar Degeneration in the Italian Population 49
Disease-modifying therapies for tauopathies: agents in the pipeline 49
Spinal cord stimulation may improve gait and cognition in hereditary spastic paraplegia with mental retardation: a case report 48
The missing ApoE allele 48
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs 47
Multiple personality and hallucinations in a patient with normal dat-scan spect fulfilling diagnostic criteria for probable dementia with lewy bodies 47
Disturbi cognitivi e comportamentali nella malattia di Parkinson 47
Obsessive-compulsive behaviour and cognitive impairment in a parkinsonian patient after left putaminal lesion 46
The RELN locus in Alzheimer's Disease 45
The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymes 45
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 44
Totale 8.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.816
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202061 0 0 0 0 0 0 0 0 0 0 0 61
2020/2021843 44 60 24 53 68 51 141 60 105 133 69 35
2021/20221.109 82 75 31 71 114 50 28 156 65 53 175 209
2022/20232.109 234 239 171 233 180 258 190 146 249 71 64 74
2023/20241.331 71 365 60 61 77 124 122 51 31 46 150 173
2024/20252.572 55 54 204 105 150 111 74 137 450 282 615 335
Totale 10.697